Z12.73

Clinical Causes: Factors increasing the risk of ovarian cancer, such as age, family history, and genetic mutations like BRCA1 and BRCA2. Personal history of breast, colorectal, or other cancers associated with genetic predispositions. Reproductive history factors including early menarche, late menopause, and nulliparity. Hormonal influences, such as prolonged use of hormone replacement therapy. Environmental and lifestyle factors like obesity, smoking, and diet.

Key Symptoms: Often no noticeable symptoms in the early stages. Bloating or increased abdominal size. Pelvic or abdominal pain. Difficulty eating or feeling full quickly. Urinary urgency or frequency. Feeling the need to urinate more often.

Diagnosis Path: Screening for ovarian cancer typically involves a combination of methods, although no single test guarantees early detection. Common screening procedures include: - **Pelvic Examination:** Physical assessment to detect enlarged ovaries or abnormal masses. - **Ultrasound Imaging:** Transvaginal or abdominal ultrasound to visualize ovarian structures. - **Blood Tests:** Measurement of tumor markers such as CA-125 levels, though these are not definitive on their own. If screening results indicate abnormal findings, further diagnostic procedures like ultrasound-guided biopsies or surgical exploration may be recommended to confirm or rule out malignancy.

Treatment Protocols: Since the focus here is on screening, treatment options are not directly addressed. However, if ovarian cancer is detected, treatment typically involves a combination of surgical intervention and chemotherapy. The specific approach depends on the cancer stage, patient health, and other factors. Screening programs aim to identify potential issues early, providing a window for timely treatment to improve survival outcomes. It's important to work closely with healthcare professionals to determine appropriate screening schedules and follow-up procedures based on individual risk factors.